Inventisbio
Shanghai, CN · 4 known investors
InventisBio (益方生物) is a biopharmaceutical company that develops small-molecule drugs, including candidates targeting KRAS G12C for lung and pancreatic cancer and treatments for moderate-to-severe plaque psoriasis. Based in Shanghai, China, it focuses on oncology and other therapeutic areas with a global outlook.
BiotechHealthtech
Investors · 4
Frequently asked questions
- What does Inventisbio do?
- InventisBio (益方生物) is a biopharmaceutical company that develops small-molecule drugs, including candidates targeting KRAS G12C for lung and pancreatic cancer and treatments for moderate-to-severe plaque psoriasis. Based in Shanghai, China, it focuses on oncology and other therapeutic areas with a global outlook.
- Who are Inventisbio's investors?
- Inventisbio's investors include LAV, Lilly Asia Ventures, OrbiMed, Qiming Venture Partners.
- Where is Inventisbio headquartered?
- Inventisbio is headquartered in Shanghai, CN.